Sunday 21 February 2016

Portfolio Performance

This blog was initially started to document my investment journey back in 2011 (unfortunately, many of my early entries were accidentally deleted). As time goes by, my focus gradually shifted to nus module review. Now that my undergraduate years are over and is actively building my portfolio, I think it is time to revert this blog to its original intent.

Let me start with my portfolio performance for the past 5 years.


The returns were computed using XIRR and benchmarked against dollar cost averaging (DCA) the STI index (subjected to 1% sale charge and inclusive of dividends). To read this plot, the % return is the per annum gain if the entire portfolio was liquidated at that point in time. For example, if I liquidated my portfolio in early 2013, my return would be ard 20% p.a. for the period of investment. Alternatively, If I were to liquidate my portfolio last Friday (22 Feb 2016), my return would be around 17% per year for the last 5 years. This is in contrast with the near 0% return of the DCA portfolio.

Over the past 5 years, my investment theme has changed. When I first started, my focus was on high yield counters (mainly REITs). However, ever since Ben Bernanke, then FED chairman, announced QE tapering, my target shifted to low-debt-high-cash companies that are less vulnerable to interest rate hikes. My current portfolio consist of the following stocks:

Company
Share
Sheng Siong
5000
Raffles Medical
1000
Singtel
2500
Parkway Life REIT
2000
Total Value
S$ 22,270

Going forward, I will continue to be actively seeking investment opportunities to grow my portfolio. Hopefully it can grow to $100,000 by early 2018, barring any financial Armageddon.